Inactive Instrument
CUSPIS CAP L Share Price Toronto S.E.
Stocks
CUSP.P
CA23168X1078
Specialty Chemicals
OTC Markets Traded| Market Cap | 252M 177M 154M 143M 131M 248M 16.89B 1.69B 662M 8.41B 665M 650M 28.2B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 252M 177M 154M 143M 131M 248M 16.89B 1.69B 662M 8.41B 665M 650M 28.2B | EV / Sales 2026 * |
90x | EV / Sales 2027 * | 3.45x |
| Free-Float |
86.07% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +14.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Nicol
CEO | Chief Executive Officer | 51 | 09/08/2016 |
Joshua George
DFI | Director of Finance/CFO | - | 07/04/2024 |
Stuart Watson
PRN | Corporate Officer/Principal | - | 21/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Nicol
BRD | Director/Board Member | 51 | 09/08/2016 |
Robert Galyen
BRD | Director/Board Member | - | 30/06/2023 |
Jack Perkowski
CHM | Chairman | 76 | 23/10/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +14.14% | +41.25% | - | - | 177M | ||
| +2.99% | -4.83% | +73.75% | +9.63% | 4.99B | ||
| +10.07% | +26.12% | -13.99% | -32.33% | 2.73B | ||
| +5.38% | -8.04% | -18.01% | +66.42% | 707M | ||
| +0.14% | +14.99% | -8.64% | -48.53% | 618M | ||
| +5.29% | +6.46% | +24.74% | +7.50% | 568M | ||
| +1.73% | +6.27% | -24.49% | -16.49% | 275M | ||
| +0.73% | +23.82% | -34.72% | -2.13% | 275M | ||
| +4.61% | +7.43% | -47.52% | -49.52% | 197M | ||
| Average | +4.88% | +8.62% | -6.11% | -8.18% | 1.29B | |
| Weighted average by Cap. | +5.00% | +6.61% | +28.97% | -3.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.8M 1.97M 1.71M 1.59M 1.46M 2.76M 188M 18.75M 7.36M 93.41M 7.38M 7.22M 313M | 73M 51.24M 44.55M 41.46M 38.07M 71.89M 4.89B 489M 192M 2.44B 192M 188M 8.17B |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Specialty Chemicals
















